Xilio Therapeutics | ARS:年度報告
04/25 16:23 (美東)
Xilio Therapeutics | DEFA14A:其他
04/25 16:16 (美東)
Xilio Therapeutics | DEF 14A:股東委託書決議
04/25 16:09 (美東)
Xilio Therapeutics | 424B5:募資說明書
04/15 09:04 (美東)
Xilio Therapeutics | SC 13G:超過5%持股股東披露文件-Gilead Sciences, Inc.(19.9%)
04/05 16:36 (美東)
Xilio Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Rock Springs Capital Management LP(8.71%),Rock Springs Capital LLC(8.71%)等
04/05 14:54 (美東)
Xilio Therapeutics | 4:持股變動聲明-股東 GILEAD SCIENCES, INC.
04/03 18:54 (美東)
Xilio Therapeutics | 3:首次持股聲明-股東 GILEAD SCIENCES, INC.
04/03 18:54 (美東)
Xilio Therapeutics | S-8:員工福利計劃證券登記
04/01 16:29 (美東)
Xilio Therapeutics | 10-K:年度報表
04/01 16:27 (美東)
Xilio Therapeutics | 8-K:Xilio Therapeutics公佈管道和業務最新情況以及2023年第四季度和全年財務業績
04/01 16:20 (美東)
Xilio Therapeutics | 8-K:重大事件
03/28 16:17 (美東)
Xilio Therapeutics | 8-K:重大事件
03/28 07:59 (美東)
Xilio Therapeutics | SC 13G:超過5%持股股東披露文件-Rock Springs Capital Management LP(5.23%),Rock Springs Capital LLC(5.23%)
02/14 14:19 (美東)
Xilio Therapeutics | 4:持股變動聲明-股東 Atlas Venture Fund XI, L.P.
02/09 16:36 (美東)
Xilio Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-OCTAGON CAPITAL ADVISORS LP(0%),OCTAGON INVESTMENTS MASTER FUND LP(0%)等
02/06 16:11 (美東)
Xilio Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-OCTAGON CAPITAL ADVISORS LP(6.48%),OCTAGON INVESTMENTS MASTER FUND LP(6.48%)等
02/05 16:05 (美東)
Xilio Therapeutics | 8-K:重大事件
01/19 00:00 (美東)
Xilio Therapeutics | 4:持股變動聲明-股東 Atlas Venture Fund XI, L.P.
01/16 00:00 (美東)
Xilio Therapeutics | 4:持股變動聲明-高管 Frankenfield Christopher James
01/03 00:00 (美東)
暫無數據
暫無數據